Valuation (72%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.83 | 35.84 |
PEG Ratio (TTM) | 0.01 | 9.82 |
P/S Ratio (TTM) | 0.79 | 7.68 |
P/B Ratio (TTM) | 4.29 | 4.45 |
P/FCF Ratio (TTM) | 17.06 | 16.22 |
Price to 5YR AVG Earnings Ratio | 9.81 | 76.88 |
Price to 5YR AVG FCF Ratio | 7.09 | 59.96 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | -18.95% | 6.15% |
ROE (TTM) | -78.31% | 13.71% |
Net Profit Margin (TTM) | -27.86% | 6.45% |
ROIC 5YR AVG | 15.77% | 12.41% |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -236.21% | -7.80% | -7.92% |
Revenue | -4.44% | 7.51% | 8.78% |
Net Income | -236.77% | -9.17% | -10.18% |
Cash Flow | 70.23% | 6.79% | -1.45% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.92 | 1.55 |
Quick Ratio (TTM) | 1.07 | 1.10 |
D/E Ratio (TTM) | 5.35 | 0.73 |
Interest Coverage (TTM) | 2.40 | 13.46 |
Piotroski F-Score | 5 | 7 |
Altman Z-Score | 1.00 | 3.87 |
LTL to 5YR AVG FCF | 7.44 | 9.57 |
Shares Outstanding Growth 5YR AVG | -2.76% | 33.14% |